Glucocorticoid receptor – beta-2 adrenergic receptor cross-talk (GR-ADRB2 cross-talk)

The Glucocorticoid receptor – beta-2 adrenergic receptor cross-talk refers to the synergistic molecular interaction between the glucocorticoid receptor (GR), a nuclear transcription factor (UniProt P04150), and the beta-2 adrenergic receptor (ADRB2), a G protein-coupled receptor (UniProt P07550). This interaction is the pharmacological basis for the combination of inhaled corticosteroids (ICS) and long-acting beta-2 agonists (LABA) used in respiratory medicine (Barnes, P. J., 2011, European Respiratory Journal). Glucocorticoids enhance the expression of ADRB2 by increasing gene transcription and preventing the receptor's desensitization caused by chronic agonist exposure (Giembycz, M. A., & Newton, R., 2015, Expert Review of Respiratory Medicine). Simultaneously, beta-2 agonists facilitate the translocation of the GR from the cytoplasm to the nucleus and augment its binding to glucocorticoid response elements, thereby amplifying anti-inflammatory gene expression (PubMed: 21030471). This bidirectional synergy allows for superior control of airway inflammation and bronchoconstriction compared to monotherapy. Clinically, targeting this cross-talk is essential for managing chronic inflammatory airway diseases like asthma and chronic obstructive pulmonary disease (COPD) (NIH, National Heart, Lung, and Blood Institute).

Other names

GR-beta2AR interactionCorticosteroid-beta2-agonist synergyICS-LABA synergyGlucocorticoid receptor and beta-2 adrenoceptor interactionGR-ADRB2 signaling axis

The mechanism involves a bidirectional synergy where glucocorticoids increase the transcription of the ADRB2 gene and prevent receptor desensitization, while beta-2 agonists promote the nuclear translocation and transcriptional activity of the glucocorticoid receptor.